Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prenatal Diagnosis | 10 | 2015 | 165 | 2.100 |
Why?
|
| Genetic Testing | 9 | 2015 | 381 | 1.520 |
Why?
|
| DNA | 8 | 2014 | 1352 | 1.020 |
Why?
|
| Fetal Membranes, Premature Rupture | 2 | 2023 | 34 | 0.900 |
Why?
|
| Chorioamnionitis | 1 | 2023 | 35 | 0.850 |
Why?
|
| Placenta | 2 | 2023 | 622 | 0.740 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2020 | 20 | 0.730 |
Why?
|
| Fetal Diseases | 2 | 2011 | 145 | 0.710 |
Why?
|
| Zika Virus Infection | 1 | 2020 | 85 | 0.670 |
Why?
|
| Fetal Growth Retardation | 1 | 2023 | 466 | 0.630 |
Why?
|
| Pregnancy | 15 | 2023 | 5540 | 0.600 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2020 | 288 | 0.570 |
Why?
|
| Microbiota | 1 | 2023 | 654 | 0.510 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2014 | 14 | 0.480 |
Why?
|
| Trisomy | 1 | 2014 | 66 | 0.450 |
Why?
|
| Fetal Viability | 1 | 2012 | 4 | 0.410 |
Why?
|
| Preimplantation Diagnosis | 1 | 2012 | 4 | 0.410 |
Why?
|
| Polycystic Kidney, Autosomal Recessive | 1 | 2012 | 6 | 0.410 |
Why?
|
| Moral Obligations | 1 | 2012 | 10 | 0.410 |
Why?
|
| Fertilization in Vitro | 1 | 2012 | 72 | 0.390 |
Why?
|
| Obstetrics | 1 | 2011 | 163 | 0.330 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 983 | 0.310 |
Why?
|
| Running | 4 | 2015 | 211 | 0.300 |
Why?
|
| Decision Making | 1 | 2012 | 795 | 0.250 |
Why?
|
| Aneuploidy | 3 | 2015 | 86 | 0.240 |
Why?
|
| Female | 19 | 2023 | 59773 | 0.240 |
Why?
|
| Parents | 1 | 2012 | 1197 | 0.230 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2011 | 1177 | 0.220 |
Why?
|
| Amniotic Fluid | 1 | 2023 | 64 | 0.210 |
Why?
|
| Preconception Care | 1 | 2022 | 30 | 0.210 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2023 | 126 | 0.210 |
Why?
|
| Attitude to Health | 3 | 2015 | 405 | 0.210 |
Why?
|
| Fractures, Stress | 2 | 2013 | 33 | 0.200 |
Why?
|
| Reproduction | 1 | 2022 | 182 | 0.190 |
Why?
|
| Mosquito Vectors | 1 | 2020 | 21 | 0.190 |
Why?
|
| Mosquito Control | 1 | 2020 | 24 | 0.180 |
Why?
|
| Cell-Free System | 4 | 2014 | 48 | 0.180 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 50 | 0.180 |
Why?
|
| Microcephaly | 1 | 2020 | 54 | 0.180 |
Why?
|
| Delivery, Obstetric | 1 | 2020 | 119 | 0.170 |
Why?
|
| Tocolysis | 1 | 2019 | 4 | 0.170 |
Why?
|
| Humans | 20 | 2023 | 115297 | 0.170 |
Why?
|
| Tocolytic Agents | 1 | 2019 | 15 | 0.170 |
Why?
|
| Obstetric Labor, Premature | 1 | 2019 | 33 | 0.160 |
Why?
|
| Endothelial Cells | 1 | 2023 | 685 | 0.160 |
Why?
|
| Maternal Serum Screening Tests | 1 | 2015 | 3 | 0.130 |
Why?
|
| Premature Birth | 1 | 2019 | 273 | 0.130 |
Why?
|
| Bone Density | 2 | 2015 | 437 | 0.110 |
Why?
|
| Pregnancy Trimester, First | 1 | 2014 | 127 | 0.110 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 2012 | 16 | 0.110 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 2012 | 10 | 0.110 |
Why?
|
| United States | 6 | 2014 | 12310 | 0.100 |
Why?
|
| Chromosome Aberrations | 1 | 2012 | 130 | 0.100 |
Why?
|
| Fetus | 2 | 2013 | 701 | 0.100 |
Why?
|
| Genetic Counseling | 1 | 2011 | 66 | 0.090 |
Why?
|
| Nurse Midwives | 1 | 2011 | 25 | 0.090 |
Why?
|
| Blood Chemical Analysis | 1 | 2011 | 92 | 0.090 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2011 | 28 | 0.090 |
Why?
|
| Sex Characteristics | 1 | 2015 | 642 | 0.090 |
Why?
|
| Genetic Markers | 1 | 2011 | 339 | 0.090 |
Why?
|
| Bone Density Conservation Agents | 1 | 2010 | 61 | 0.090 |
Why?
|
| Nurse Practitioners | 1 | 2011 | 104 | 0.090 |
Why?
|
| Logistic Models | 1 | 2014 | 1849 | 0.080 |
Why?
|
| Vitamin D | 1 | 2010 | 340 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2010 | 459 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2011 | 1355 | 0.070 |
Why?
|
| Surveys and Questionnaires | 3 | 2014 | 4635 | 0.070 |
Why?
|
| RNA | 1 | 2011 | 816 | 0.060 |
Why?
|
| Calcium | 1 | 2010 | 1107 | 0.060 |
Why?
|
| Athletic Injuries | 1 | 2010 | 455 | 0.060 |
Why?
|
| Diet | 1 | 2010 | 1093 | 0.060 |
Why?
|
| Adult | 4 | 2022 | 30576 | 0.050 |
Why?
|
| Male | 5 | 2015 | 55796 | 0.050 |
Why?
|
| Health Surveys | 2 | 2014 | 443 | 0.050 |
Why?
|
| Risk Factors | 4 | 2015 | 8684 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 2019 | 114 | 0.040 |
Why?
|
| Public Health | 1 | 2022 | 442 | 0.040 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2019 | 127 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2015 | 1989 | 0.040 |
Why?
|
| Gestational Age | 1 | 2019 | 753 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 301 | 0.030 |
Why?
|
| Bone Demineralization, Pathologic | 1 | 2015 | 2 | 0.030 |
Why?
|
| Adolescent | 4 | 2015 | 17767 | 0.030 |
Why?
|
| Middle Aged | 2 | 2015 | 26936 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 2 | 2013 | 1393 | 0.030 |
Why?
|
| Thinness | 1 | 2015 | 87 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2015 | 220 | 0.030 |
Why?
|
| Basketball | 1 | 2013 | 11 | 0.030 |
Why?
|
| Dancing | 1 | 2013 | 14 | 0.030 |
Why?
|
| Intellectual Property | 1 | 2013 | 5 | 0.030 |
Why?
|
| Sex Determination Analysis | 1 | 2013 | 5 | 0.030 |
Why?
|
| Physical Conditioning, Human | 1 | 2013 | 24 | 0.030 |
Why?
|
| Gymnastics | 1 | 2013 | 20 | 0.030 |
Why?
|
| Menarche | 1 | 2013 | 51 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 2015 | 217 | 0.030 |
Why?
|
| Commerce | 1 | 2013 | 56 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2013 | 107 | 0.030 |
Why?
|
| Sports | 1 | 2015 | 174 | 0.030 |
Why?
|
| Decision Trees | 1 | 2012 | 81 | 0.030 |
Why?
|
| Laboratories | 1 | 2013 | 95 | 0.030 |
Why?
|
| Informed Consent | 1 | 2013 | 161 | 0.030 |
Why?
|
| Feeding and Eating Disorders | 1 | 2013 | 118 | 0.030 |
Why?
|
| Iliotibial Band Syndrome | 1 | 2011 | 1 | 0.020 |
Why?
|
| Fasciitis, Plantar | 1 | 2011 | 3 | 0.020 |
Why?
|
| Patellofemoral Pain Syndrome | 1 | 2011 | 7 | 0.020 |
Why?
|
| San Francisco | 1 | 2011 | 56 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 1734 | 0.020 |
Why?
|
| Health Personnel | 1 | 2013 | 580 | 0.020 |
Why?
|
| Incidence | 1 | 2013 | 2325 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 2440 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2015 | 2988 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 2247 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 4423 | 0.020 |
Why?
|
| Child | 1 | 2022 | 18435 | 0.010 |
Why?
|
| Military Personnel | 1 | 2010 | 524 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2013 | 6236 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 10413 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2011 | 12588 | 0.010 |
Why?
|